Anxiety News and Research

Latest Anxiety News and Research

Opiate abuse may alter brain neurons making brain more sensitive to stress

If the research proves applicable to humans, the findings may help explain how hospital patients who have received morphine may be susceptible to stress disorder, attention problems and sleep disturbances.

27 Sep 2004

Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder

AstraZeneca has announced important new data at the 4th European Stanley Foundation Conference on Bipolar Disorder, which show Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder and is also well-tolerated in this difficult to treat patient population.

26 Sep 2004

Terror fears raise women's level of protein linked to heart disease

Israeli women with chronic fears of terror attacks have higher levels of a blood protein that measures low-grade inflammation and may lead to heart disease, according to a new study.

23 Sep 2004

Link between mother’s stress levels during pregnancy and the effect on the brain of her unborn baby

An intriguing link between a mother’s stress levels during pregnancy and the effect on the brain of her unborn baby is revealed in a new study of children born in Bristol, England.

20 Sep 2004

Israeli clinicians keen on using placebos in treating patients

Three out of five Israeli clinicians report using placebos – inactive treatments or drugs – in treating patients, despite the medical profession's official disapproval of their use, say the authors of a BMJ Online First paper this week.

17 Sep 2004

ChemGenex discovers five new depression genes

ChemGenex Pharmaceuticals has announced that it has filed for patent protection for a further five novel depression-associated gene targets discovered by its depression and anxiety research group.

16 Sep 2004

Prozac, Paxil, Wellbutrin, Zoloft, Celexa, Effexor, Luvox and Remeron should have "Black Box" warnings

A panel of experts has voted 15 to 8 in favour of the Federal Food and Drug Administration (FDA) adding black box warnings to certain medications used to treat depression in children and teenagers.

14 Sep 2004

Findings that may help explain links between the stress of traumatic events and increased risk of cardiac death

Reporting findings that may help explain links between the stress of traumatic events and increased risk of cardiac death, researchers said the rate of potentially life-threatening heart arrhythmias doubled during the month after the World Trade Center terrorist attack in 2001 in patients with implantable cardioverter-defibrillators, not only in the New York area, but also in Florida

14 Sep 2004

Many factors influence quality of life for patients with irritable bowel syndrome

The quality of life for patients with irritable bowel syndrome is as related to non-gastrointestinal (GI) symptoms, including tiring easily and feeling tense, as it is to GI symptoms associated with the disorder

12 Sep 2004

Spouses' emotions can effect psychological recovery after a heart attack or angioplasty

Psychological recovery after a heart attack or angioplasty may be delayed if patients’ spouses feel even more anxious or depressed than their ill partners, researchers say.

10 Sep 2004

Computer scientists developing nurturing computers

Imagine a day when your computer will be able to let you know if you need a break, alert you to take medication or even go to the doctor.

10 Sep 2004

Painful and damaging chemotherapy may one day be a thing of the past

Researchers at the Georgia Institute of Technology and Purdue University have developed nano-sized particles that can target and trick cancer cells into absorbing them.

10 Sep 2004

Chemical pathways of serotonin in the nervous system pave way for future pharmaceutical treatments for depression

From mollusks to mammals, newly discovered chemical pathways of serotonin in the nervous system are paving a path toward future pharmaceutical treatments for depression and other disorders.

10 Sep 2004

Cymbalta approved for diabetic peripheral neuropathy pain

The U.S. Food and Drug Administration has approved Eli Lilly's Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor. Cymbalta is the first and only FDA-approved treatment for pain caused by diabetic peripheral neuropathy.

8 Sep 2004

FDA approval for chewable ADHD tablets

Alliant Pharmaceuticals has announced FDA approval of Methylin Chewable Tablets and Methylin Oral Solution for the treatment of ADHD. The two products are the first, and only, chewable tablet and oral solution for ADHD to gain FDA acceptance.

7 Sep 2004

Pediatricians do not always feel comfortable or sufficiently trained to tackle the increasing growth in ADHD patient numbers

Attention Deficit Hyperactivity Disorder (ADHD) is a neurobehavioral disorder that affects 3-5 percent of all American children. Today pediatricians appear to be treating more children with these behavioral health problems.

7 Sep 2004

Sight of a friendly face can reduce stress in sheep

This discovery, published in the journal Proceedings of the Royal Society: Biological Sciences, could point to the reason that many of us carry pictures of loved ones in our wallets or handbags.

6 Sep 2004

Rural doctors less likely to diagnose depression in men than in women

It is known that doctors are generally less likely to diagnose depression in men than in women. Little research has been undertaken to explore the reasons for this in rural settings, or to compare GPs' and male patients' assessments of perceived depression.

2 Sep 2004

Counseling for breast cancer patients means healthier diets, reduced smoking and stronger immune systems

Regular psychological counseling for breast cancer patients may do more than just lower their stress and anxiety. A new study says the right kind of intervention can also mean healthier diets, reduced smoking, and most surprising of all – a stronger immune system.

2 Sep 2004

New sedation procedure which could allow patients to avoid potentially risky general anaesthetics

Dental experts have developed a new sedation procedure which could relieve pressure on hospitals and allow patients to avoid potentially risky general anaesthetics.

1 Sep 2004

Anxiety News and Research

Latest Anxiety News and Research

Opiate abuse may alter brain neurons making brain more sensitive to stress

Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder

Terror fears raise women's level of protein linked to heart disease

Link between mother’s stress levels during pregnancy and the effect on the brain of her unborn baby

Israeli clinicians keen on using placebos in treating patients

ChemGenex discovers five new depression genes

Prozac, Paxil, Wellbutrin, Zoloft, Celexa, Effexor, Luvox and Remeron should have "Black Box" warnings

Findings that may help explain links between the stress of traumatic events and increased risk of cardiac death

Many factors influence quality of life for patients with irritable bowel syndrome

Spouses' emotions can effect psychological recovery after a heart attack or angioplasty

Computer scientists developing nurturing computers

Painful and damaging chemotherapy may one day be a thing of the past

Chemical pathways of serotonin in the nervous system pave way for future pharmaceutical treatments for depression

Cymbalta approved for diabetic peripheral neuropathy pain

FDA approval for chewable ADHD tablets

Pediatricians do not always feel comfortable or sufficiently trained to tackle the increasing growth in ADHD patient numbers

Sight of a friendly face can reduce stress in sheep

Rural doctors less likely to diagnose depression in men than in women

Counseling for breast cancer patients means healthier diets, reduced smoking and stronger immune systems

New sedation procedure which could allow patients to avoid potentially risky general anaesthetics

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Anxiety News and Research

Latest Anxiety News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in